Was Massive news in relation to ANP and where it now sits us, in the DMD trials basically leading the field, Sarepta,s MC dropped approx $5bil overnight from memory
Sarepta Therapeutics' Duchenne muscular dystrophy (DMD) gene therapy has failed to beat placebo in a phase 2 clinical trial. ... At 48 weeks, children treated with the gene therapy had a 1.7 mean improvement on the 17-point NSAA functional motor ability scale.8 Jan 2021
